[Clinical evaluation of a new oral cephalosporin preparation, cephradine dry syrup, in pediatrics (author's transl)].
D001991:Bronchitis / Q000188:drug therapy; D002511:Cephalosporins / Q000008:administration & dosage*; D002515:Cephradine / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D007223:Infant; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008297:Male; D014677:Pharmaceutical Vehicles; D011014:Pneumonia / Q000188:drug therapy; D011511:Proteus / Q000187:drug effects; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012541:Scarlet Fever / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D014522:Urethral Diseases / Q000188:drug therapy
D002511:Cephalosporins; D014677:Pharmaceutical Vehicles; D002515:Cephradine